Clinical study to evaluate effect and safety of herbal formulation DRDC/2022/040 on Intragastric pHâ?? A randomized, open label, comparative, cross over, interventional, prospective study - NI

Dabur Research Development Centre Dabur India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•1.Healthy male and female subjects
•2.Clinically normal physical findings at the time of screening visit
•3.Laboratory values (CBC, CT, BT, Liver profile) within the normal range
•4.Negative Urine pregnancy test at the time of screening for female participants
•5.Ready to sign informed consent form and follow study procedure

•1. Immunocompromised subjects or those suffering from any serious or debilitating medical condition;
•2. Subjects with current drug, tobacco or alcohol abuse;
•3. Subjects with diabetes/hypertension;
•4. Subjects with presence of any disease/condition or physical defect which could preclude subjects from complying with study procedures.
•5. Subjects receiving treatment with any medication which could alter or influence stomach acidity or study drug/placebo activity;
•6. Subjects who investigator feels may be unreliable or unsuitable to participate in a clinical trial
•7. Subject having participated in a clinical trial in the previous 30 days
•8. Pregnant and Lactating females

发起方

Dabur Research Development Centre Dabur India Limited